Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FTC pursues firms advertising "free" product trials

This article was originally published in The Tan Sheet

Executive Summary

The Federal Trade Commission follows through with its promise to enforce against marketers that falsely promise "free" product trials. The commission says it will announce Aug. 16 a lawsuit against a firm that allegedly marketed free trials of acai berry weight-loss and colon-cleansing supplements. FTC warned in February 2009 it would pursue firms that enrolled consumers in a "negative option" continuity program under which consumers are charged without consent for reoccurring shipments unless the consumer cancels. Marketers advertising acai products with negative option schemes caught the attention of Connecticut Attorney General Richard Blumenthal, the Center for Science in the Public Interest and the Council of Better Business Bureaus (1"The Tan Sheet" March 30, 2009)

You may also be interested in...

Acai Offered As Bait In Latest Marketing Scams To Draw Investigations

Trendy supplement ingredient acai is the latest lure in what the Federal Trade Commission calls "negative-option" online marketing scams

EU Ban Looms On Cosmetic Microplastic: Time To Dig In On Biodegradable Plastic Criteria?

Biodegradable plastic alternatives for use in cosmetic products were left unaddressed, and thus arguably unusable, under the US Microbead-Free Waters Act enacted in late 2015. European industry stakeholders now face the prospect of a far more extensive microplastic ban, and the viability of bioplastics to replace conventional, petroleum-based microplastics is an area in need of work.

More GMP Warnings, Import Alerts For OTC Firms As US FDA Capped List Of Uninspected Facilities

Most of the foreign OTC drug firms targeted in latest warnings FDA published, including the GUM oral care brand manufacturer, were placed on import alert due to GMP violations. Each was inspected by FDA during June, July or May 2019, when the agency was wrapping up an initiative to inspect all previously uninspected drug manufacturers.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts